463 Metastatic gastric cancer patient benefiting from combined radio-immunotherapy treatment displayed sustained anti-NY-ESO-1 specific T cells and expressed important immuno-modulatory markers

• Maysaloun Merhi,
• Afsheen Raza,
• Fairooz Sahir,
• Sarra Mestiri,
• Shereena Hydrose,
• Niloofar Allahverdi,
• Munir Jalis,
• Allan Relecom,
• Mai Mostafa,
• Shahab Uddin,
• Varghese Inchakalody,
• Siveen Kodappully,
• Deepak Choubey,
• Lobna Al-Zaidan,
• Mohamed Sir Elkhatim Hamid,
• Abdul Rehman Zar Gul,
• Mohammed Ussama Al Homsi,
• Said Dermine

Affiliations

Maysaloun Merhi

Medical Oncology, Hamad Medical Corporation, Doha, Ad Dawhah, Qatar

Afsheen Raza

Medical Oncology, Hamad Medical Corporation, Doha, Ad Dawhah, Qatar

Fairooz Sahir

Hamad Medical Corporation, Doha, Ad Dawhah, Qatar

Sarra Mestiri

Hamad Medical Corporation, Doha, Ad Dawhah, Qatar

Shereena Hydrose

Hamad Medical Corporation, Doha, Ad Dawhah, Qatar

Niloofar Allahverdi

Hamad Medical Corporation, Doha, Ad Dawhah, Qatar

Munir Jalis

Hamad Medical Corporation, Doha, Ad Dawhah, Qatar

Allan Relecom

Hamad Medical Corporation, Doha, Ad Dawhah, Qatar

Mai Mostafa

Hamad Medical Corporation, Doha, Ad Dawhah, Qatar

Shahab Uddin

Hamad Medical Corporation, Doha, Ad Dawhah, Qatar

Varghese Inchakalody

Hamad Medical Corporation, Doha, Qatar

Siveen Kodappully

Hamad Medical Corporation, Doha, Qatar

Deepak Choubey

Hamad Medical Corporation, Doha, Qatar

Lobna Al-Zaidan

Hamad Medical Corporation, Doha, Qatar

Mohamed Sir Elkhatim Hamid

Hamad Medical Corporation, Doha, Qatar

Abdul Rehman Zar Gul

Hamad Medical Corporation, Doha, Qatar

Mohammed Ussama Al Homsi

Hamad Medical Corporation, Doha, Qatar

Said Dermine

Hamad Medical Corporation, Doha, Qatar